SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE

被引：0
作者：
Lupusoru, Gabriela Elena [1 ,2 ]
Ailincai, Ioana-Georgiana [2 ]
Sorohan, Bogdan Marian [1 ,2 ]
Andronesi, Andreea Gabriella [1 ,2 ]
Lupusoru, Mircea [3 ]
Andronesi, Danut [4 ]
Manda, Dana [5 ]
Caragheorgheopol, Andra [5 ]
Ismail, Gener [1 ,2 ]
机构：
[1] Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania
[2] Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Physiol Dept, Bucharest, Romania
[4] Fundeni Clin Inst, Gen Surg & Liver Transplant Dept, Bucharest, Romania
[5] CI Parhon Natl Inst Endocrinol, Res Dept, Bucharest, Romania
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO648
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
[31]   Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity [J].
Raff, Hershel ;
Phillips, Jonathan M. ;
Simpson, Pippa M. ;
Weisman, Steven J. ;
Hainsworth, Keri R. .
PAIN REPORTS, 2020, 5 (04)
[32]   Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency [J].
Hoybye, Charlotte ;
Faseh, Laia ;
Himonakos, Christos ;
Pielak, Tomasz ;
Eugen-Olsen, Jesper .
ENDOCRINE CONNECTIONS, 2019, 8 (06) :772-779
[33]   Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia [J].
Guo, Hong ;
Zhou, Lan-Xia ;
Ma, Haizhen ;
Liu, Bei ;
Cheng, Juan ;
Ma, Yun-Yun ;
Zhao, Li .
ONCOLOGY LETTERS, 2017, 14 (01) :383-389
[34]   Soluble Urokinase Plasminogen Activator Receptor Levels Predict Incident Cardio-Kidney-Metabolic Disease Risk [J].
Yadalam, Adithya ;
Liu, Chang ;
Sun, Yan ;
Quyyumi, Arshed .
CIRCULATION, 2024, 150
[35]   Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients [J].
Rafał Nikodem Wlazeł ;
Iwona Szadkowska ;
Piotr Bartnicki ;
Kinga Rośniak-Bąk ;
Jacek Rysz .
International Urology and Nephrology, 2018, 50 :339-345
[36]   Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients [J].
Wlazel, Rafal Nikodem ;
Szadkowska, Iwona ;
Bartnicki, Piotr ;
Rosniak-Bak, Kinga ;
Rysz, Jacek .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (02) :339-345
[37]   Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia [J].
Nielsen, Jimmi ;
Roge, Rasmus ;
Pristed, Sofie Gry ;
Viuff, Anne Grethe ;
Ullum, Henrik ;
Thorner, Lise Wegner ;
Werge, Thomas ;
Vang, Torkel .
SCHIZOPHRENIA BULLETIN, 2015, 41 (03) :764-771
[38]   Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure [J].
Hayek, Salim S. ;
Tahhan, Ayman Samman ;
Ko, Yi-An ;
Alkhoder, Ayman ;
Zheng, Shuai ;
Bhimani, Ravila ;
Hartsfield, Joy ;
Kim, Jonathan ;
Wilson, Peter ;
Shaw, Leslee ;
Wei, Changli ;
Reiser, Jochen ;
Quyyumi, Arshed A. .
JOURNAL OF CARDIAC FAILURE, 2023, 29 (02) :158-167
[39]   Serum soluble urokinase plasminogen activator receptor in alcoholics: Relation to liver disease severity, fibrogenesis, and alcohol use [J].
Tuomi, Heidi ;
Kultti, Johanna ;
Danielsson, Joanna ;
Kangastupa, Paivikki ;
Akerman, Kari ;
Niemela, Onni .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) :1991-1995
[40]   Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients [J].
Arientova, Simona ;
Matuskova, Katerina ;
Bartos, Oldrich ;
Beran, Ondrej ;
Holub, Michal .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
12345